XORTX Therapeutics Inc banner

XORTX Therapeutics Inc
NASDAQ:XRTX

Watchlist Manager
XORTX Therapeutics Inc Logo
XORTX Therapeutics Inc
NASDAQ:XRTX
Watchlist
Price: 0.4032 USD -17.71% Market Closed
Market Cap: $1.2m

Income Statement

Earnings Waterfall
XORTX Therapeutics Inc

Income Statement
XORTX Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Nov-2013 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Revenue
814
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
(643)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gross Profit
171
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(170)
(0)
(1)
(1)
(2)
(2)
(3)
(3)
(7)
(9)
(11)
(10)
(10)
(8)
(8)
(6)
(5)
(5)
(4)
(4)
(4)
(3)
(3)
Selling, General & Administrative
(69)
(0)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(4)
(4)
(3)
(4)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(3)
(3)
(3)
Research & Development
(98)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(3)
(5)
(6)
(7)
(6)
(5)
(4)
(2)
(1)
(1)
(0)
(0)
(0)
(1)
(1)
Depreciation & Amortization
(2)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Operating Income
1
N/A
(0)
N/A
(1)
-103%
(1)
-39%
(2)
-80%
(2)
-33%
(3)
-1%
(3)
-2%
(7)
-155%
(9)
-39%
(11)
-18%
(10)
+4%
(10)
+3%
(8)
+16%
(8)
+8%
(6)
+22%
(5)
+14%
(5)
+5%
(4)
+10%
(4)
+7%
(4)
+3%
(3)
+15%
(3)
+5%
Pre-Tax Income
Interest Income Expense
0
(0)
(0)
(0)
(1)
(1)
(9)
3
5
6
15
3
4
2
2
4
2
4
4
1
3
2
1
Non-Reccuring Items
(4)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
0
(2)
(1)
0
0
(1)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Pre-Tax Income
(2)
N/A
(0)
+81%
(1)
-114%
(1)
-20%
(3)
-257%
(3)
+5%
(11)
-243%
(1)
+90%
(3)
-151%
(4)
-47%
3
N/A
(8)
N/A
(7)
+13%
(7)
-2%
(7)
-3%
(2)
+69%
(3)
-55%
(1)
+56%
(1)
+50%
(3)
-350%
(1)
+70%
(2)
-89%
(2)
-3%
Net Income
Tax Provision
(19)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(21)
(0)
(1)
(1)
(3)
(3)
(11)
(1)
(3)
(4)
3
(8)
(7)
(7)
(7)
(2)
(3)
(1)
(1)
(3)
(1)
(2)
(2)
Net Income (Common)
(21)
N/A
(0)
+98%
(1)
-114%
(1)
-20%
(3)
-257%
(3)
+5%
(11)
-243%
(1)
+90%
(3)
-151%
(4)
-47%
3
N/A
(8)
N/A
(7)
+13%
(7)
-2%
(7)
-3%
(2)
+69%
(3)
-55%
(1)
+56%
(1)
+50%
(3)
-350%
(1)
+70%
(2)
-89%
(2)
-3%
EPS (Diluted)
-0.77
N/A
-0.05
+94%
-0.12
-140%
-1.3
-983%
-0.41
+68%
-0.34
+17%
-1.19
-250%
-1.06
+11%
-0.22
+79%
-0.32
-45%
0.22
N/A
-5.22
N/A
-3.48
+33%
-3.42
+2%
-3.5
-2%
-1.09
+69%
-1.37
-26%
-0.5
+64%
-0.25
+50%
-1.15
-360%
-0.26
+77%
-0.49
-88%
-0.4
+18%